Souza Dias M Beatriz, Habert Alina Bernardes, Borrasca Vera, Stempliuk Valeska, Ciolli Aina, Araújo M Rita E, Costa Silvia F, Levin Anna S
Infection Control Department, Hospital Sírio Libanês, University of São Paulo, Brazil.
Infect Control Hosp Epidemiol. 2008 Feb;29(2):125-30. doi: 10.1086/526440.
To describe the management of patients with long-term central venous catheters (CVCs) during an outbreak of infection due to Pseudomonas putida and Stenotrophomonas maltophilia associated with contaminated heparin catheter-lock solution.
Descriptive study.
Private, 250-bed tertiary-care hospital.
In March 2003, we identified 2 febrile cancer patients with P. putida bacteremia. Over 2 days, 7 cases of bacteremia were identified; lots of syringes prefilled with heparin catheter-lock solution, supplied by a compounding pharmacy, were recalled and samples were cultured. More cases of bacteremia appeared during the following days, and any patient who had had a catheter lock infused with the suspect solution was asked to provide blood samples for culture, even if the patient was asymptomatic. Isolates that were recovered from culture were typed by pulsed-field gel electrophoresis. Antimicrobial salvage treatment of long-term CVCs was attempted.
A total of 154 patients had had their catheter lock infused with solution from the lots that were suspected of being contaminated. Only 48 of these patients had CVCs. By day 7 of the outbreak, 18 of these patients had become symptomatic. Twenty-six of the remaining 30 asymptomatic patients then also provided blood samples for culture, 10 of whom developed fever shortly after samples were collected. Thirty-two patients were identified who had P. putida bacteremia; 9 also had infection due to S. maltophilia. Samples from 1 of the 3 lots of prefilled syringes in use at the time of the outbreak also grew P. putida on culture. Molecular typing identified 3 different clones of P. putida from patients and heparin catheter-lock solution, and 1 clone of S. maltophilia. A total of 27 patients received antimicrobial therapy regimens, some of which included decontamination of the catheter lock with anti-infective lock solution. Of 27 patients, 19 (70%) retained their long-term CVC during the 6-month follow-up period.
To our knowledge, this is one of the largest prospective experiences in the management of bloodstream infection associated with long-term CVCs. The infections were caused by gram-negative bacilli and were managed without catheter removal, with a high response rate. We emphasize the risks of using intravenous formulations of medications supplied by compounding pharmacies that produce large quantities of drugs.
描述在因与受污染的肝素导管封管溶液相关的恶臭假单胞菌和嗜麦芽窄食单胞菌感染暴发期间,长期中心静脉导管(CVC)患者的管理情况。
描述性研究。
拥有250张床位的私立三级护理医院。
2003年3月,我们确定了2例患有恶臭假单胞菌血症的发热癌症患者。在2天内,共确定了7例菌血症病例;召回了由一家配制药房供应的大量预充肝素导管封管溶液的注射器,并对样本进行培养。在接下来的几天里出现了更多菌血症病例,任何接受过用可疑溶液封管的患者都被要求提供血样进行培养,即使患者无症状。对培养分离出的菌株进行脉冲场凝胶电泳分型。尝试对长期CVC进行抗菌挽救治疗。
共有154例患者接受了来自疑似受污染批次的溶液封管。这些患者中只有48例有CVC。在暴发的第7天,其中18例患者出现症状。其余30例无症状患者中的26例随后也提供了血样进行培养,其中10例在采集样本后不久出现发热。确定了32例患有恶臭假单胞菌血症的患者;9例还感染了嗜麦芽窄食单胞菌。暴发时正在使用的3批预充注射器中的1批样本在培养时也培养出了恶臭假单胞菌。分子分型从患者和肝素导管封管溶液中鉴定出3种不同的恶臭假单胞菌克隆和1种嗜麦芽窄食单胞菌克隆。共有27例患者接受了抗菌治疗方案,其中一些方案包括用抗感染封管溶液对导管封管进行去污处理。27例患者中,19例(70%)在6个月的随访期内保留了其长期CVC。
据我们所知,这是长期CVC相关血流感染管理方面最大的前瞻性经验之一。感染由革兰氏阴性杆菌引起,并在不拔除导管的情况下进行管理,反应率很高。我们强调使用由大量生产药物的配制药房提供的静脉用药制剂的风险。